Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ: BLAC · Real-Time Price · USD
11.62
+0.02 (0.17%)
Nov 21, 2024, 12:02 PM EST - Market open
BLAC Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -0.47 | 0.4 | -0.04 | -0 | -0.03 |
| Other Operating Activities | -2.14 | -2.78 | - | - | - |
| Change in Accounts Payable | 0.76 | 1.04 | 0.03 | 0 | - |
| Change in Income Taxes | -0.1 | 0.52 | - | - | - |
| Change in Other Net Operating Assets | -0 | -0.01 | - | - | - |
| Operating Cash Flow | -1.96 | -0.82 | -0 | -0 | -0.03 |
| Other Investing Activities | 53.31 | -33.83 | - | - | - |
| Investing Cash Flow | 53.31 | -33.83 | - | - | - |
| Short-Term Debt Issued | - | 0.4 | 0.82 | 0.11 | - |
| Total Debt Issued | 1.99 | 0.4 | 0.82 | 0.11 | 0.36 |
| Short-Term Debt Repaid | - | -1.54 | -0.01 | - | - |
| Total Debt Repaid | -0.34 | -1.54 | -0.01 | - | - |
| Net Debt Issued (Repaid) | 1.65 | -1.15 | 0.81 | 0.11 | 0.36 |
| Issuance of Common Stock | - | 73.13 | - | - | 0.03 |
| Repurchase of Common Stock | -53.04 | -36 | - | - | - |
| Other Financing Activities | - | -1.45 | -0.68 | -0.17 | -0.29 |
| Financing Cash Flow | -51.39 | 34.54 | 0.12 | -0.06 | 0.1 |
| Net Cash Flow | -0.05 | -0.11 | 0.12 | -0.06 | 0.08 |
| Free Cash Flow | -1.96 | -0.82 | -0 | -0 | -0.03 |
| Free Cash Flow Per Share | -0.36 | -0.11 | -0.00 | -0.00 | -0.02 |
| Cash Income Tax Paid | 0.02 | 0.02 | - | - | - |
| Levered Free Cash Flow | -0.13 | 0.77 | -0.27 | 0.27 | - |
| Unlevered Free Cash Flow | -0.13 | 0.77 | -0.27 | 0.27 | - |
| Change in Net Working Capital | -1.27 | -1.91 | 0.25 | -0.28 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.